SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-008205
Filing Date
2022-03-30
Accepted
2022-03-30 17:22:06
Documents
62
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1132890
2 ex31-1.htm EX-31.1 14854
3 ex31-2.htm EX-31.2 15117
4 ex32-1.htm EX-32.1 8663
5 form10-k_001.jpg GRAPHIC 3815
6 form10-k_002.jpg GRAPHIC 56351
7 form10-k_003.jpg GRAPHIC 152286
8 form10-k_004.jpg GRAPHIC 91846
  Complete submission text file 0001493152-22-008205.txt   4552613

Data Files

Seq Description Document Type Size
9 INLINE XBRL INSTANCE DOCUMENT crxm-20201231.xml EX-101.INS 555636
10 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crxm-20201231.xsd EX-101.SCH 38343
11 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crxm-20201231_cal.xml EX-101.CAL 55722
12 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crxm-20201231_def.xml EX-101.DEF 166225
13 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crxm-20201231_lab.xml EX-101.LAB 304161
14 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crxm-20201231_pre.xml EX-101.PRE 243850
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Gene Biotherapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33635 | Film No.: 22787817
SIC: 2836 Biological Products, (No Diagnostic Substances)